• 1
    Johnson L, Boon J, Orton EC. Clinical characteristics of 53 dogs with Doppler-derived evidence of pulmonary hypertension: 1992–1996. J Vet Intern Med 1999;13:440447.
  • 2
    Pyle RL, Abbott J, MacLean H. Pulmonary hypertension and cardiovascular sequelae in 54 dogs. Intern J Appl Res Vet Med 2004;2:99109.
  • 3
    Fleming E, Ettinger SJ. Pulmonary hypertension. Compend Contin Educ Pract Vet 2006;28:720730.
  • 4
    Bach JF, Rozansky EA, MacGregor J, et al. Retrospective evaluation of sildenafil citrate as a therapy for pulmonary hypertension in dogs. J Vet Intern Med 2006;20:11321135.
  • 5
    Schober KE, Baade H. Doppler echocardiography prediction of pulmonary hypertension in West Highland White Terriers with chronic pulmonary disease. J Vet Intern Med 2006;20:912920.
  • 6
    Galiè N, Torbicki A, Barst R, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The task force on diagnosis and treatment of pulmonary arterial hypertension of the European Society of Cardiology. Eur Heart J 2004;25:22432278.
  • 7
    Johnson LR, Hamlin RL. Recognition and treatment of pulmonary hypertension. In: BonaguraK, ed. Current Veterinary Therapy, XII ed. Philadelphia, PA: WB Saunders; 1995:887891.
  • 8
    Corcoran BM, Cobb M, Martin MW, et al. Chronic pulmonary disease in West Highland White Terriers. Vet Rec 1999;144:611616.
  • 9
    Glaus TM, Hassig M, Baumgartner C, Reusch CE. Pulmonary hypertension induced in dogs by hypoxia at different high-altitude levels. Vet Res Commun 2003;27:661670.
  • 10
    Glaus TM, Soldati G, Maurer R, et al. Clinical and pathological characterisation of primary pulmonary hypertension in a dog. Vet Rec 2004;154:786789.
  • 11
    Zabka TS, Campbell FE, Wilson DW. Pulmonary arteriopathy and idiopathic pulmonary arterial hypertension in six dogs. Vet Pathol 2006;43:510522.
  • 12
    Serres FJ, Chetboul V, Tissier R, et al. Doppler echocardiography-derived evidence of pulmonary arterial hypertension in dogs with degenerative mitral valve disease: 86 cases (2001–2005). J Am Vet Med Assoc 2006;229:17721778.
  • 13
    Kellum HB, Stepien RL. Sildenafil citrate therapy in 22 dogs with pulmonary hypertension. J Vet Intern Med 2007;21:12581264.
  • 14
    Rich S, McLaughlin VV. Pulmonary hypertension. In: ZipesDP, LibbyP, BonowRO, BraunwaldE, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed. Philadelphia, PA: Elsevier Saunders; 2005:18071842.
  • 15
    Wensel R, Opitz CF, Anker SD, et al. Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation 2002;106:319324.
  • 16
    Torbicki A, Kurzyna M, Kuca P, et al. Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension. Circulation 2003;108:844848.
  • 17
    Wells SM, Sleeper M. Cardiac troponins. J Vet Emerg Crit Care 2008;18:235245.
  • 18
    Babuin L, Jaffe AS. Troponin: The biomarker of choice for the detection of cardiac injury. Can Med Assoc J 2005;173:11911202.
  • 19
    Rishniw M, Barr SC, Simpson KW, et al. Cloning and sequencing of the canine and feline cardiac troponin I genes. Am J Vet Res 2004;65:5358.
  • 20
    Sleeper MM, Clifford CA, Laster LL. Cardiac troponin I in the normal dog and cat. J Vet Intern Med 2001;15:501503.
  • 21
    Adin DB, Milner RJ, Berger KD, et al. Cardiac troponin I concentrations in normal dogs and cats using a bedside analyzer. J Vet Cardiol 2005;7:2732.
  • 22
    Schober KE, Kirback B, Oechtering G. Noninvasive assessment of myocardial cell injury in dogs with suspected cardiac contusion. J Vet Cardiol 1999;1:1725.
  • 23
    Schober KE, Cornand C, Kirbach B, et al. Serum cardiac troponin I and cardiac troponin T concentrations in dogs with gastric dilatation-volvulus. J Am Vet Med Assoc 2002;221:381388.
  • 24
    Lobetti R, Dvir E, Pearson J. Cardiac troponins in canine babesiosis. J Vet Intern Med 2002;16:6368.
  • 25
    DeFrancesco TC, Atkins CE, Keene BW, et al. Prospective clinical evaluation of serum cardiac troponin T in dogs admitted to a veterinary teaching hospital. J Vet Intern Med 2002;16:553557.
  • 26
    Shaw SP, Rozanski EA, Rush JE. Cardiac troponin I and T in dogs with pericardial effusion. J Vet Intern Med 2004;18:322324.
  • 27
    Spratt DP, Mellanby RJ, Drury N, et al. Cardiac troponin I: Evaluation of a biomarker for the diagnosis of heart disease in the dog. J Small Anim Pract 2005;46:139145.
  • 28
    Oyama MA, Sisson DD. Cardiac troponin-I concentration in dogs with cardiac disease. J Vet Intern Med 2004;18:831839.
  • 29
    Burgener IA, Kovacevic A, Mauldin N, et al. Cardiac troponins as indicators of acute myocardial damage in dogs. J Vet Intern Med 2006;20:227283.
  • 30
    Linde A, Summerfield NJ, Sleeper MM, et al. Pilot study on cardiac troponin I levels in dogs with pericardial effusion. J Vet Cardiol 2006;8:1923.
  • 31
    Baumwart RD, Orvalho J, Meurs KM. Evaluation of serum cardiac troponin I concentration in Boxers with arrhythmogenic right ventricular cardiomyopathy. Am J Vet Res 2007;68:524528.
  • 32
    Pelander L, Häggström J, Jones B. Troponin I – a possible marker of myocardial cell damage in the dog? Eur J Comp Anim Pract 2002;12:6671.
  • 33
    Meyer T, Binder L, Hruska N, et al. Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. J Am Coll Cardiol 2000;36:16321636.
  • 34
    Douketis JD, Crowther MA, Stanton EB, et al. Elevated cardiac troponin levels in patients with submassive pulmonary embolism. Arch Intern Med 2002;162:7981.
  • 35
    Adam T, Kurzyna M, Kuca P, et al. Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension. Circulation 2003;108:844848.
  • 36
    Konstantinides S, Geibel A, Olschewski M, et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 2002;106:12631268.
  • 37
    Thomas W P, Gaber CE, Jacobs J, et al. Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. J Vet Intern Med 1993;7:247252.
  • 38
    Boon JA. Evaluation of size, function and hemodynamics. In: BoonJA, ed. Manual of Veterinary Echocardiography. Baltimore, MD: Williams & Wilkins Co; 1998:151260.
  • 39
    Kittleson MD, Kienle RD. Pulmonary arterial and systemic arterial hypertension. In: KittlesonMD, KienleRD, eds. Small Animal Cardiovascular Medicine. Saint Louis, MO: Mosby; 1998:433439.
  • 40
    International Small Animal Cardiac Health Council. Recommendations for diagnosis of heart disease and treatment of heart failure in small animals. In: FoxPR, SissonD, MoïseNS, eds. Textbook of Canine and Feline Cardiology, 2nd ed. Philadelphia, PA: WB Saunders; 1999:883901.
  • 41
    Mastrorilli C, Dondi F, Agnoli C, et al. Clinicopathologic features and outcome predictors of Leptospira interrogans australis serogroup infection in dogs: Retrospective study of 20 cases (2001–2004). J Vet Intern Med 2007;21:310.
  • 42
    Uzuelli JA, Dias-Junior CA, Tanus-Santos JE. Severity dependent increases in circulating cardiac troponin I and MMP-9 concentrations after experimental acute pulmonary thromboembolism. Clin Chim Acta 2008;388:184188.
  • 43
    McDonald MA, Ross HJ. Trying to succeed when the right ventricle fails. Curr Opin Cardiol 2009;24:239245.
  • 44
    Adin DB, Oyama MA, Sleeper MM, et al. Comparison of canine cardiac troponin I concentrations as determined by 3 different analyzers. J Vet Intern Med 2006;20:11361142.
  • 45
    Borgarelli M, Savarino P, Crosara S, et al. Survival characteristics and prognostic variables of dogs with mitral regurgitation attributable to myxomatous valve disease. J Vet Intern Med 2008;22:120128.
  • 46
    Chiavegato D, Borgarelli M, D'Agnolo G, Santilli RA. Pulmonary hypertension in dogs with mitral regurgitation attributable to myxomatous valve disease. Vet Radiol Ultrasound 2009;50:253258.
  • 47
    Logeart D, Lecuyer L, Thabut G, et al. Biomarker-based strategy for screening right ventricular dysfunction in patients with non-massive pulmonary embolism. Intensive Care Med 2007;33:286292.
  • 48
    Roongsritong C, Warraich I, Bradley C. Common causes of troponin elevations in the absence of acute myocardial infarction: Incidence and clinical significance. Chest 2004;125:18771884.
  • 49
    Giannitsis E, Muller-Bardoff M, Kurowsky V, et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000;102:211217.
  • 50
    Mikulewicz M, Lewczuk J. Importance of cardiac biomarkers in acute pulmonary embolism. Cardiol J 2008;15:1720.
  • 51
    Becattini C, Vedovati MC, Agnelli G. Diagnosis and prognosis of acute pulmonary embolism: Focus on serum troponins. Expert Rev Mol Diagn 2008;8:339349.
  • 52
    Punukollu G, Khan IA, Gowda RM, et al. Cardiac troponin I release in acute pulmonary embolism in relation to duration of symptoms. Int J Cardiol 2005;99:207211.
  • 53
    Johnson L, Lappin MR, Baker DC. Pulmonary thromboembolism in 29 dogs: 1985–1995. J Vet Intern Med 1999;13:338345.
  • 54
    MacDonald KA, Johnson LR. Pulmonary hypertension and pulmonary thromboembolism. In: EttingerSJ, FeldmanEC, eds. Textbook of Veterinary Internal Medicine, 6th ed. Philadelphia, PA: Elsevier Saunders; 2005:12841288.
  • 55
    Serres FJ, Chetboul V, Gouni V, et al. Diagnostic value of echo-Doppler and Doppler tissue imaging in dogs with pulmonary arterial hypertension. J Vet Intern Med 2007;21:12801289.